1-8 of 8
Michael Jeffers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Chemotherapy, Phd-Inhibitor Molidustat or BRD4 Inhibitor JQ1 in Combination with Targeted Inhibition of Mutated IDH1 in Human AML In Vivo

Anuhar Chaturvedi, PhD, Charu Gupta, Stefan Kaulfuss, PhD, Basem Othman, Kerstin Görlich, Renate Schottmann, Olaf Panknin, Markus Wagner, PhD, Arnold Ganser, MD, Michael Jeffers, PhD, Andrea Haegebarth, Michael Heuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3933.
https://doi.org/10.1182/blood-2019-124016
Published: 2019
Journal Articles

Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia

Anuhar Chaturvedi, PhD, Charu Gupta, Ramya Goparaju, Razif Gabdoulline, PhD, Stefan Kaulfuss, PhD, Kerstin Görlich, Renate Schottmann, Olaf Panknin, Markus Wagner, PhD, Robert Geffers, PhD, Arnold Ganser, MD, Felicitas Thol, MD, Michael Jeffers, PhD, Andrea Haegebarth, Michael Heuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1352.
https://doi.org/10.1182/blood.V130.Suppl_1.1352.1352
Published: 2017
Journal Articles

The Role of Marrow Fibrosis in the Prognosis and Treatment of Myelodysplastic Syndromes: a Single Center Retrospective Study

Emma M Groarke, MRCPI, Su Wai Maung, MRCP, MBBS, FRCPath, Karl Ewins, MRCPI, Michael Jeffers, FRCPath, Johnny McHugh, FRCPath, Ronan Desmond, MD FRCPath, Helen Enright, MD FRCPI, FRCPath
Journal: Blood
Blood (2016) 128 (22): 5524.
https://doi.org/10.1182/blood.V128.22.5524.5524
Published: 2016
Journal Articles

Increased p53 Expression in Patients with Therapy-Related MDS/AML Is Common and May be Associated with a Poor Prognosis

Su Wai Maung, MBBS, MRCP(UK), Niamh Strahan, MSc, Sarah O'Dowd, M.Sc, John O'Loughlin, Ronan Desmond, MD FRCPath, Johnny McHugh, FRCPath, Michael Jeffers, FRCPath, Helen Enright, MD FRCPI, FRCPath
Journal: Blood
Blood (2015) 126 (23): 5245.
https://doi.org/10.1182/blood.V126.23.5245.5245
Published: 2015
Journal Articles

Changes in p53 Expression By Immunohistochemistry during Azacitidine Therapy in Patients with MDS Can Predict Overall Prognosis

Su Wai Maung, MBBS, MRCP(UK), Niamh Strahan, M.Sc, Philomena O'Byrne, M.Sc, Sarah O'Dowd, M.Sc, John O'Loughlin, Ronan Desmond, MD FRCPath, Johnny McHugh, FRCPath, Michael Jeffers, FRCPath, Helen Enright, MD FRCPI, FRCPath
Journal: Blood
Blood (2015) 126 (23): 2878.
https://doi.org/10.1182/blood.V126.23.2878.2878
Published: 2015
Journal Articles

Phase I Study of Intravenous PI3K Inhibitor Bay 80–6946: Preliminary Activity in Patients with Relapsed Non-Hodgkin Lymphoma (NHL) Treated in an MTD Expansion Cohort

Amita Patnaik, MD, Ramesh K Ramanathan, MD, Leonard Joseph Appleman, MD, PhD, Anthony W Tolcher, MD, FRCP, James M Mountz, MD, PhD, Muralidhar Beerham, MD, Glen J Weiss, MD, Drew W Rasco, MD, Michael T Lotze, MD, Frederico GS Toledo, MD, Matthew J Oborski, MS, Prabhu Rajagopalan, PhD, Michael Jeffers, PhD, Andrea Kelly, Isabelle Genvresse, MD
Journal: Blood
Blood (2012) 120 (21): 3704.
https://doi.org/10.1182/blood.V120.21.3704.3704
Published: 2012
Journal Articles

Effects of a Novel Histone Deacetylase Inhibitor, PXD101, When Used as Monotherapy or in Combination with Bortezomib on Tumor Growth in Mouse Models of Human Multiple Myeloma.

Richard A. Campbell, Eric Sanchez, Haiming Chen, MD, PhD, Lauren Turker, Olivia Trac, Mingjie Li, Dror Shalitin, PhD, Melinda S. Gordon, PhD, Shen Pang, PhD, Benjamin Bonavida, PhD, Jonathan Said, MD, Michael Jeffers, Xiaozhong Qian, Henri S. Lichenstein, PhD, James R. Berenson, MD
Journal: Blood
Blood (2006) 108 (11): 3483.
https://doi.org/10.1182/blood.V108.11.3483.3483
Published: 2006
Journal Articles

Activity of the Histone Deacetylase (HDAC) Inhibitor PXD101 in Preclinical Studies and in a Phase I Study in Patients with Advanced Haematological Tumors.

Peter Gimsing, MD, Frank Wu, PhD, Xiaozhong Qian, PhD, Michael Jeffers, PhD, Lene Knudsen, MD, Maxwell Sehested, MD, PhD, Henri S. Lichenstein, PhD
Journal: Blood
Blood (2005) 106 (11): 3337.
https://doi.org/10.1182/blood.V106.11.3337.3337
Published: 2005